We further explored the predictive value of osteopontin, MMP-2, MMP-9 and VEGF-C by testing their abundance in a subgroup of patients with incident osteonecrosis where blood samples were available before, during and after the event and comparing their values with those of patients who remained free from osteonecrosis. This evidence concerns the gene SPP1 and osteonecrosis.